Subscribe To
Belite bio reports full-year 2022 operational highlights and financial results
12-month interim data from the ongoing 2-year, Phase 2 Stargardt disease (STGD1) study continues to show halting or slowing of lesion growth; 18-month...
March 31, 2023, 11:03 pm